Herbs (Global Traditional) · Ayurveda
Kantakari (Solanum virginianum) (Solanum virginianum)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Kantakari (Solanum virginianum) is an Ayurvedic herb containing steroidal alkaloids like solasodine that may support respiratory function. Traditional uses focus on bronchitis and asthma, though clinical evidence remains limited to animal studies.
Kantakari (Solanum virginianum) is a prickly herbaceous plant from the Solanaceae family, native to India, Sri Lanka, and tropical regions, commonly found in wastelands and cultivated areas. The whole plant, particularly roots, fruits, leaves, flowers, and seeds, serves as the medicinal source, traditionally prepared as juice (swaras), powder (churna), or decoction (kwath).
Despite extensive traditional use, the research dossier reveals no human clinical trials, RCTs, or meta-analyses with PubMed PMIDs for Kantakari. Current evidence is limited to preclinical pharmacological studies and traditional medicine claims, with no human studies documenting effects on asthma, diabetes, or other conditions.
Traditional Ayurvedic dosage ranges include: juice (swaras) 10-20 ml daily, powder (churna) 3-6 g daily, decoction (kwath) 20-30 ml daily. No clinically studied dosages or standardization protocols are available. Consult a healthcare provider before starting any new supplement.
Kantakari (Solanum virginianum) is a medicinal herb rather than a dietary food source, so conventional macronutrient profiling is limited; however, the following bioactive and nutritional constituents have been documented: Steroidal alkaloids: solasodine (0.1–0.9% dry weight in berries and leaves, highest in unripe fruits), solanine, solamargine, and solasonine — primary pharmacologically active compounds. Steroidal saponins: diosgenin and carpesterol, present in roots and aerial parts, contributing to anti-inflammatory and adaptogenic properties. Flavonoids: quercetin, kaempferol, and apigenin glycosides detected in leaf extracts at trace to moderate concentrations (reported range 0.05–0.3% dry weight). Phenolic acids: chlorogenic acid, caffeic acid, and ferulic acid identified via HPLC analysis in fruit and leaf fractions. Fixed oils in seeds: approximately 4–6% lipid content, including linoleic acid and palmitic acid as dominant fatty acids. Crude fiber: approximately 15–22% in dried aerial parts, contributing to digestive transit effects. Crude protein: approximately 10–14% in dried leaf powder, though bioavailability is not well characterized and not a primary nutritional use. Minerals (reported in dried plant material): calcium (~800–1200 mg/100g), iron (~15–25 mg/100g), phosphorus (~200–350 mg/100g), potassium (~600–900 mg/100g), magnesium (~150–250 mg/100g) — values vary significantly by soil and geography. Vitamins: Vitamin C reported at approximately 20–40 mg/100g in fresh berries; beta-carotene (provitamin A) present at trace levels in leaves. Glycoalkaloids collectively estimated at 0.2–1.5% in whole plant dry weight — these compounds contribute therapeutic activity but also impose dosage caution due to potential toxicity at high concentrations. Bioavailability note: Steroidal alkaloids show limited oral bioavailability due to first-pass metabolism; traditional preparations using decoctions (kwatha) may enhance extraction of water-soluble saponins and phenolics, while oil-based preparations (taila) may improve absorption of lipophilic constituents. No formal human pharmacokinetic studies are available as of current literature.
Kantakari's steroidal alkaloids, particularly solasodine and solamargine, appear to modulate inflammatory pathways by inhibiting pro-inflammatory cytokines and histamine release. The glycoalkaloids may also interact with bronchial smooth muscle receptors to promote bronchodilation. Hepatoprotective effects likely involve antioxidant enzyme activation and protection against oxidative stress markers.
No clinical trials on kantakari exist in humans. Animal studies suggest hepatoprotective effects at 200-400mg/kg doses in rats with chemically-induced liver damage. Respiratory benefits remain limited to traditional use reports and in vitro studies showing anti-inflammatory activity. The lack of human data makes efficacy claims premature and limits evidence-based dosing recommendations.
Kantakari safety data is extremely limited, with no established human safety profile. As a Solanum species containing glycoalkaloids, it may cause gastrointestinal irritation or neurological symptoms in high doses. Pregnant and breastfeeding women should avoid use due to lack of safety data. Potential interactions with diabetes medications are possible based on animal studies showing hypoglycemic effects.
